VC Stock Analysis: Visteon | NASDAQ
Auto Parts | NASDAQ, USA | Market Cap: 2.281m USD | 12M Return: -22.5% | US92839U2069 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.6M
EPS Trend: -36.2%
Qual. Beats: 0
Rev. Trend: -94.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Visteon Corporation is an automotive technology company that designs, manufactures, and sells automotive electronics and connected car solutions to vehicle manufacturers. Its product portfolio spans instrument clusters, information displays, infotainment and connected car systems (including Android-based platforms and AI voice assistants), display audio, battery management systems (wired and wireless), high-voltage power electronics, and its SmartCore integrated domain controller with supporting runtime and studio configuration tools. The company also markets CognitoAI, an in-house automotive-grade AI software platform, and offers engineering and software development services.
The company operates across the United States, Mexico, Portugal, Slovakia, Tunisia, other European markets, China, India, Japan, other Asia-Pacific countries, and South America. Visteon was incorporated in 2000 and is headquartered in Van Buren, Michigan. It is classified within the Consumer Discretionary sector under the Automotive Parts & Equipment sub-industry, a segment that supplies electronic and software-driven components increasingly central to vehicle differentiation as the industry shifts toward electrification, connectivity, and advanced driver assistance.
- Electrification tailwind boosts battery management and power electronics orders
- Global auto OEM production volumes drive cockpit electronics revenue
- Display technology competition intensifies against Aptiv and Continental
| Net Income: 151.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -5.74 > 1.0 |
| NWC/Revenue: 20.83% < 20% (prev 20.98%; Δ -0.16% < -1%) |
| CFO/TA 0.08 > 3% & CFO 288.0m > Net Income 151.0m |
| Net Debt (-79.0m) to EBITDA (393.0m): -0.20 < 3 |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.3m) vs 12m ago -1.09% < -2% |
| Gross Margin: 12.81% > 18% (prev 14.23%; Δ -1.43% > 0.5%) |
| Asset Turnover: 113.7% > 50% (prev 119.7%; Δ -6.05% > 0%) |
| Interest Coverage Ratio: 39.71 > 6 (EBIT TTM 278.0m / Interest Expense TTM 7.00m) |
| A: 0.23 (Total Current Assets 1.80b - Total Current Liabilities 1.01b) / Total Assets 3.46b |
| B: 0.84 (Retained Earnings 2.90b / Total Assets 3.46b) |
| C: 0.08 (EBIT TTM 278.0m / Avg Total Assets 3.32b) |
| D: 0.91 (Book Value of Equity 1.61b / Total Liabilities 1.77b) |
| Altman-Z'' = 5.75 = AAA |
| DSRI: 0.96 (Receivables 666.0m/701.0m, Revenue 3.78b/3.82b) |
| GMI: 1.11 (GM 14.23% / 12.81%) |
| AQI: 1.08 (AQ_t 0.29 / AQ_t-1 0.27) |
| SGI: 0.99 (Revenue 3.78b / 3.82b) |
| TATA: -0.04 (NI 151.0m - CFO 288.0m) / TA 3.46b) |
| Beneish M = -2.92 (Cap -4..+1) = A |
As of October 15, 2026, the stock is trading at USD 86.61 with a total of 346,400 shares traded. Over the past week, the price has changed by -0.55%, over one month by -13.40%, over three months by -16.39% and over the past year by -22.51%.
Current recommended Stop Loss: 82.50 (which is 4.7% or 1.6 ATR below the current price).
Visteon has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy VC.
- StrongBuy: 4
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 122.5 | 41.4% |
P/E Trailing = 15.6179
P/E Forward = 9.058
P/S = 0.6035
P/B = 1.5426
P/EG = 1.0072
Revenue TTM = 3.78b USD
EBIT TTM = 278.0m USD
EBITDA TTM = 393.0m USD
Long Term Debt = 284.0m USD (from longTermDebt, last quarter)
Short Term Debt = 39.0m USD (from shortTermDebt, last quarter)
Debt = 569.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 135.0m
Net Debt = -79.0m USD (calculated: Debt 569.0m - CCE 648.0m)
Enterprise Value = 2.20b USD (2.28b + Debt 569.0m - CCE 648.0m)
Interest Coverage Ratio = 39.71 (Ebit TTM 278.0m / Interest Expense TTM 7.00m)
EV/FCF = 13.76x (Enterprise Value 2.20b / FCF TTM 160.0m)
FCF Yield = 7.27% (FCF TTM 160.0m / Enterprise Value 2.20b)
FCF Margin = 4.23% (FCF TTM 160.0m / Revenue TTM 3.78b)
Net Margin = 4.00% (Net Income TTM 151.0m / Revenue TTM 3.78b)
Gross Margin = 12.81% ((Revenue TTM 3.78b - Cost of Revenue TTM 3.29b) / Revenue TTM)
Gross Margin QoQ = 12.29% (prev 11.84%)
Tobins Q-Ratio = 0.64 (Enterprise Value 2.20b / Total Assets 3.46b)
Interest Expense / Debt = 1.23% (Interest Expense 7.00m / Debt 569.0m)
Taxrate = 40.96% (111.0m / 271.0m)
NOPAT = 164.1m (EBIT 278.0m * (1 - 40.96%))
Current Ratio = 1.78 (Total Current Assets 1.80b / Total Current Liabilities 1.01b)
Debt / Equity = 0.35 (Debt 569.0m / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = -0.20 (Net Debt -79.0m / EBITDA 393.0m)
Debt / FCF = -0.49 (Net Debt -79.0m / FCF TTM 160.0m)
Total Stockholder Equity = 1.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.54% (Net Income 151.0m / Total Assets 3.46b)
RoE = 9.71% (Net Income TTM 151.0m / Total Stockholder Equity 1.55b)
RoCE = 15.12% (EBIT 278.0m / Capital Employed (Equity 1.55b + L.T.Debt 284.0m))
RoIC = 7.16% (NOPAT 164.1m / Invested Capital 2.29b)
WACC = 7.14% (E(2.28b)/V(2.85b) * Re(8.74%) + D(569.0m)/V(2.85b) * Rd(1.23%) * (1-Tc(0.41)))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.05 | Cagr: -1.12%
[DCF] Terminal Value 73.10% ; FCFF base≈228.4m ; Y1≈200.3m ; Y5≈161.8m
[DCF] Fair Price = 100.3 (EV 2.60b - Net Debt -79.0m = Equity 2.68b / Shares 26.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -36.19 | EPS CAGR: -13.69% | SUE: -0.39 | # QB: 0
Revenue Correlation: -94.79 | Revenue CAGR: -2.33% | SUE: 0.14 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.34 | Chg30d=-3.79% | Revisions=-25% | Analysts=11
EPS current Year (2026-12-31): EPS=8.44 | Chg30d=-1.14% | Revisions=-25% | GrowthEPS=+8.9% | GrowthRev=+0.8%
EPS next Year (2027-12-31): EPS=10.36 | Chg30d=-1.05% | Revisions=-25% | GrowthEPS=+22.8% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: -50% (up=0, down=3)